Large Research Projects for Combating Antibiotic-Resistant Bacteria (CARB) (R01)
Closed Posted
- Opportunity number
- PA-22-047
- Agency
-
Agency for Healthcare Research and Quality
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Grant
- Category
-
- Health
- Eligible applicants
-
- Non-501(c)(3) Nonprofits
- Special District Governments
- Higher Education Inst. (Private)
- Public or Indian Housing Auth.
- Higher Education Inst. (Public)
- County Governments
- Tribal Governments (Federally Recognized)
- State Governments
- Independent School Districts
- Other
- City/Township Governments
- Tribal Organizations (Not Federally Recognized)
- 501(c)(3) Nonprofits
- Points of contact
-
- grant_queries@ahrq.hhs.gov
- Kathryn Marron kathryn.marron@ahrq.hhs.gov (301) 427-1554
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Agency for Healthcare Research and Quality (AHRQ) within the Department of Health and Human Services is soliciting applications for Large Research Projects (R01) focused on Combating Antibiotic-Resistant Bacteria (CARB). This Funding Opportunity Announcement invites comprehensive research initiatives designed to address the critical challenge of antibiotic resistance in healthcare settings. Applicants must demonstrate scientific merit and technical capability, with evaluation emphasizing the qualifications of the principal investigator and staff, appropriate research methodology, and budget justification. Applications will be reviewed by peer committees composed of nonfederal scientific consultants, with funding decisions based on scientific merit, program relevance to identified AHRQ priorities, and available funding. The deadline for application submission is March 25, 2026, and applicants are encouraged to review the full announcement (PA-22-047) for detailed requirements and specifications.
Typical awards under the Research on Healthcare Costs, Quality and Outcomes program (CFDA 93.226) range from approximately $300,000 to $1,200,000 in average annual value, with some coordinating center awards reaching up to $4,000,000 over five-year periods. Projects are generally approved for funding periods of up to five years, depending on specific program parameters and funding availability. Research may be conducted at varied healthcare delivery settings nationwide, including hospitals, long-term care facilities, ambulatory care practices, and other clinical environments. Eligible applicants include higher education institutions, government agencies, tribal governments, and nonprofit organizations that meet AHRQ eligibility criteria.
Synopsis
This Funding Opportunity Announcement (FOA) invites applications for grant funding to conduct Large Research Projects (R01) focused on Combating Antibiotic-Resistant Bacteria (CARB) .
Files
| File | Type | Posted |
|---|---|---|
| PA-22-047-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity